Clinical outcomes of microwave ablation for solitary T1N0M0 papillary thyroid carcinoma: a more than 5-year follow-up study
European Radiology · 27.11.2024 · 35 (3) · 1714-1722
DOI: 10.1007/s00330-024-11210-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Radiology, online erschienen am 27.11.2024. Verfasst von Han-Xiao Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: China-Japan Friendship Institute of Clinical Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: Microwaves, Thyroid Neoplasms, Thyroid Cancer, Papillary, Ablation Techniques. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Research Ward Project, National High Level Hospital Clinical Research Funding.
Abstract (Originalsprache)
OBJECTIVES: This study aimed to evaluate the long-term efficacy and safety of microwave ablation (MWA) for solitary T1N0M0 papillary thyroid carcinoma (PTC) and compare them between T1a and T1b disease. MATERIALS AND METHODS: This retrospective study included 136 patients with solitary T1N0M0 PTC who were treated with MWA and followed up for more than 5 years. Outcomes were compared between patients with T1a and T1b disease. The primary outcomes were disease progression and disease-free survival (DFS). The secondary outcomes included the volume reduction rate (VRR), the rate of complete disappearance, and complications. RESULTS: During a mean follow-up period of 70.6 ± 10.5 months, the overall disease progression rate was 5.88%. The incidences of lymph node metastases (LNMs) and new tumors were 2.21% and 5.15%, respectively. No patient was diagnosed with local recurrence, distant metastasis, or death due to PTC. There were no significant differences between the T1a and T1b groups in terms of disease progression (3.81% vs 12.90%, p = 0.15), LNMs (1.90% vs 3.23%, p = 0.54), or new tumors (2.86% vs 12.90%, p = 0.08). The 5-year DFS rate was 94.85%, the VRR was 99.7% ± 2.0%, and 97.79% of the tumors disappeared. Hoarseness occurred in five patients (3.68%). CONCLUSION: MWA is a long-term effective and safe option for patients with solitary T1N0M0 PTC, providing a minimally invasive alternative for those who refuse surgery or active surveillance. KEY POINTS: Question MWA, as a minimally invasive alternative for treating PTC, lacks comparison with surgical resection and active surveillance. Findings MWA resulted in overall disease progression in 5.88% of patients with solitary T1N0M0 PTC over more than 5 years of follow-up. Clinical relevance MWA is a safe, effective, and minimally invasive treatment for solitary T1N0M0 PTC, with high DFS rates and low complication rates, benefiting patients seeking alternatives to surgery or active surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- China-Japan Friendship Institute of Clinical Medical Sciences, Beijing, China.
- Department of Interventional Medicine, China-Japan Friendship Hospital, Beijing, China.
- Department of Interventional Medicine, China-Japan Friendship Hospital, Beijing, China. yma301@163.com.
Förderung
- National Natural Science Foundation of China
- Beijing Research Ward Project
- National High Level Hospital Clinical Research Funding
Zitieren
APA
Zhao, H. X., Wei, Y., Zhao, Z. L., Peng, L. L., Li, Y., Wu, J., Cao, S. L., Yu, N., & Yu, M. A. (2024). Clinical outcomes of microwave ablation for solitary T1N0M0 papillary thyroid carcinoma: a more than 5-year follow-up study. European Radiology, 35(3), 1714-1722. https://doi.org/10.1007/s00330-024-11210-8
Vancouver
Zhao HX, Wei Y, Zhao ZL, Peng LL, Li Y, Wu J, et al. Clinical outcomes of microwave ablation for solitary T1N0M0 papillary thyroid carcinoma: a more than 5-year follow-up study. European Radiology. 2024;35(3):1714-1722. doi:10.1007/s00330-024-11210-8
BibTeX
@article{Zhao2024,
author = {Zhao, Han-Xiao and Wei, Ying and Zhao, Zhen-Long and Peng, Li-Li and Li, Yan and Wu, Jie and Cao, Shi-Liang and Yu, Na and Yu, Ming-An},
title = {Clinical outcomes of microwave ablation for solitary T1N0M0 papillary thyroid carcinoma: a more than 5-year follow-up study},
journal = {European Radiology},
year = {2024},
volume = {35},
number = {3},
pages = {1714--1722},
doi = {10.1007/s00330-024-11210-8}
}
EUVIMED